Later evidence has shown that Nav1.7 may also contribute to the regulation of feeding and obesity through a centrally mediated mechanism, but given that its role in pain is thought to be peripheral, this may not have a significant impact on Nav1.7 inhibitors that do not pass the blood–brain barrier (Branco et al., 2016). Here, SCN9A is linked to Obesity.